Use of peptides of general formula I X-SEQ ID No.1-Y in the...
Use of peroxidized lipids as agents intended to prevent...
Use of pharmaceutical compositions capable of being gelled...
Use of phenylethylamine derivatives for the antimicrobial...
Use of phenylpropanolamine as a mucus secretogogue in the upper
Use of photochromic coloring agent in a cosmetic composition, an
Use of piperine as a bioavailability enhancer
Use of piperine as a bioavailability enhancer
Use of piperine to increase the bioavailability of nutritional c
Use of polyalkylamine polymers in controlled release devices
Use of polydeoxyribonucleotides in diabetic neuropathies
Use of polymerized lipid diagnostic agents
Use of polymers as biocides
Use of polymers as film-forming barrier materials
Use of polyphenols to treat skin conditions
Use of polyphenols to treat skin conditions
Use of polysiloxanes containing quarternary amino groups as...
Use of purified surface modifiers to prevent particle aggregatio
Use of purinergic receptor agonists as antineoplastic agents
Use of purinergic receptor agonists as antineoplastic agents